Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 2,005-2,016 of 6,115
Behavioral study icon
Not recruitingISRCTN69603913

Internet-assisted therapy for adults with depressive symptoms: a study for the effectiveness of interpersonal therapy (IPT) compared to cognitive behaviour therapy (CBT)

This study is not recruiting in Australia. It focuses on depression.

In Australia
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyOtherOver 18 Years
Countries
Australia
Sponsor
Centre for Mental Health Research (CMHR) - The Australian National University (ANU) (Australia)
Condition
Depression, Anxiety
Behavioral study icon
Not recruitingISRCTN66683128

PST4PPD: Problem Solving Therapy for Postpartum Depression, a home visit intervention for low-income Latina mothers

This study is looking at whether a digital support tool can help people with Postpartum Depression or Mental and Behavioural Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
University of Houston
Condition
Depression
Drug study icon
CompletedEUCTR 2018-001963-22

A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subject with treatment-resistant depression in ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugA study involving a medication or substance.
Countries
Poland
Sponsor
Celon Pharma SA
Condition
Depression, Bipolarity
Drug study icon
TerminatedEUCTR 2017-002232-16

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-653 in the Treatment of Subjects with Treatment-Resistant Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company, Ltd
Condition
Depression
Drug study icon
TerminatedEUCTR 2006-006089-40

High dose corticosteroid pulses in treatment-resistant depression : a randomized double-blind placebo-controlled pilot study

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
University Hospitals Bristol NHS Foundation Trust
Condition
Depression
Drug study icon
CompletedEUCTR 2010-023414-31

Ketamine in treatment resistant major depression (TRD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Germany
Sponsor
Medizinische Fakultät. Otto von Guericke Universität
Condition
Depression
Drug study icon
CompletedEUCTR 2005-003251-13

Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
AstraZeneca UK Ltd
Condition
Depression
Drug study icon
CompletedEUCTR 2015-003413-26

Understanding the molecular basis for the use of adjunctive anti-inflammatory treatment in treatment resistant depression: a stratified, randomised, placebo-controlled, experimental medicine study ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
Depression
Behavioral study icon
WithdrawnNCT05268497

Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression

This study was withdrawn in the United States. It is testing Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression.

Multiple locations, including New Haven
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT00212797

2 Doses of Org 34517 for depression

This study is completed. It is testing 2 Doses of Org 34517 for depression.

Location not clearly listed
Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Sponsor
Merck Sharp & Dohme LLC
Condition
Depression, Schizophrenia
Drug study icon
CompletedNCT02918318

Fixed Doses of Intranasal Esketamine for treatment-resistant depression

This study is completed in Japan. It is testing fixed Doses of Intranasal Esketamine for treatment-resistant depression.

Multiple locations, including Akita
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 20 Years to 64 Years
Countries
Japan
Sponsor
Janssen Pharmaceutical K.K.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.